Universal Beteiligungs und Servicegesellschaft mbH Reduces Position in Intuitive Surgical, Inc. $ISRG

Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 351,135 shares of the medical equipment provider’s stock after selling 9,825 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Intuitive Surgical were worth $199,137,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Draper Asset Management LLC increased its holdings in Intuitive Surgical by 41.9% in the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after buying an additional 1,485 shares during the last quarter. SteelPeak Wealth LLC increased its holdings in Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after buying an additional 9,364 shares during the last quarter. Atlantic Union Bankshares Corp increased its holdings in Intuitive Surgical by 19.3% in the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after buying an additional 3,676 shares during the last quarter. World Investment Advisors increased its holdings in Intuitive Surgical by 238.3% in the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after buying an additional 3,803 shares during the last quarter. Finally, E. Ohman J or Asset Management AB increased its holdings in Intuitive Surgical by 4.1% in the third quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock valued at $12,659,000 after buying an additional 1,123 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. BTIG Research reissued a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a report on Wednesday. Truist Financial decreased their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Sanford C. Bernstein lifted their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Finally, Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $596.45.

Intuitive Surgical Trading Down 3.1%

Shares of NASDAQ ISRG opened at $451.29 on Wednesday. The stock has a 50 day simple moving average of $477.79 and a 200-day simple moving average of $515.63. The company has a market cap of $160.27 billion, a PE ratio of 57.20, a P/E/G ratio of 3.64 and a beta of 1.68. Intuitive Surgical, Inc. has a 12-month low of $427.84 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.81 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president owned 409 shares of the company’s stock, valued at approximately $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Double beat on revenue and EPS; robust procedure growth (worldwide procedures ~17%, da Vinci +16%, Ion +39%) supports durable demand for systems and consumables. Reuters: Intuitive Surgical beats quarterly expectations
• Positive Sentiment: Company reiterated growth initiatives — digital innovation and broader availability of Force Feedback — which could expand procedure mix and drive longer-term consumable and software revenue. Yahoo: Q1 highlights & digital progress
• Neutral Sentiment: Analyst views remain mostly constructive (average “Moderate Buy” / several firms maintain Buy ratings) but some price targets have been trimmed ahead of Q1. These mixed analyst moves temper near-term upside. American Banking News: Broker ratings
• Negative Sentiment: Shares slipped after hours despite the beat — investors noted the full-year guidance raise was smaller than the quarterly beat implied, suggesting management expects some slowdown or is being conservative. Yahoo: Why Intuitive dropped despite beat
• Negative Sentiment: Ongoing weakness in some international markets and the fact that a handful of firms trimmed price targets before results increase execution risk for near-term revenue cadence. Yahoo: Notes on international challenges

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.